Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Agenus Inc. - Common Stock
(NQ:
AGEN
)
3.060
-0.150 (-4.67%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Agenus Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
↗
March 13, 2023
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Earnings Preview For Agenus
↗
March 13, 2023
Via
Benzinga
Agenus Presents Clinical Data Demonstrating Durable Responses For Colorectal Cancer Candidate
↗
January 23, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
↗
December 22, 2022
Via
Benzinga
Looking Into Agenus's Return On Capital Employed
↗
December 05, 2022
Via
Benzinga
Why Shares of Agenus Rose 12.5% on Friday
↗
December 02, 2022
Agenus presented data this week on a combination therapy.
Via
The Motley Fool
Agenus (AGEN) Q3 2022 Earnings Call Transcript
↗
November 08, 2022
AGEN earnings call for the period ending September 30, 2022.
Via
The Motley Fool
7 Hot Stocks to Book Profits In Before 2023
↗
December 19, 2022
With major macroeconomic headwinds appearing on the horizon, it’s time for investors to consider the hot stocks to book profits in.
Via
InvestorPlace
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
↗
November 15, 2022
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...
Via
Benzinga
VBI Vaccines, Agenus Ink Partnership For Combination Brain Cancer Therapy
↗
October 12, 2022
Via
Benzinga
Why Agenus Stock Rose 18.4% on Thursday
↗
October 06, 2022
The company's shares climbed with help from insider buying.
Via
The Motley Fool
Miniso Group, Monday.com And Other Big Gainers From Monday
↗
November 15, 2022
U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 200 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
↗
November 14, 2022
Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.
Via
Benzinga
Short Volatility Alert: Agenus Inc.
↗
August 31, 2022
On Tuesday, shares of Agenus Inc. (NASDAQ: AGEN) experienced volatile short activity. After the activity, the stock price went down 0.00% to $2.66. The overall sentiment for AGEN has been Neutral.
Via
Benzinga
Recap: Agenus Q2 Earnings
↗
August 09, 2022
Agenus (NASDAQ:AGEN) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
↗
November 14, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
10 Best Medical Stocks Under $5
↗
October 29, 2022
The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the...
Via
Talk Markets
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 10, 2022
Gainers Reshape Lifesciences (NASDAQ:RSLS) shares increased by 12.7% to $0.34 during Monday's after-market session. The market value of their outstanding shares is at $1.2 million.
Via
Benzinga
Tilray Brands, Canopy Growth, Cronos Group And Other Big Gainers From Thursday
↗
October 07, 2022
U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Thursday. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
↗
October 07, 2022
Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.
Via
Benzinga
7 Penny Stocks That Actually Have a Buy Rating
↗
September 19, 2022
Penny stocks are always a risky proposition. However, investors can still find penny stocks with buy ratings right now.
Via
InvestorPlace
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
↗
October 06, 2022
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...
Via
Benzinga
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
↗
September 12, 2022
Via
Benzinga
Agenus Begins Mid-Stage Global Studies On Colorectal And Skin Cancer Candidate
↗
September 12, 2022
Agenus (NASDAQ: AGEN) has initiated Phase 2 ACTIVATE trials of botensilimab to advance globally in metastatic patients who have progressed on available therapies. This global Phase 2 program include...
Via
Benzinga
Agenus Earnings Perspective: Return On Capital Employed
↗
September 01, 2022
According to Benzinga Pro data, during Q2, Agenus (NASDAQ:AGEN) posted sales of $20.93 million. Earnings were up 2.71%, but Agenus still reported an overall loss of $49.23 million.
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
↗
August 01, 2022
Via
Benzinga
Agenus Commences Initial-Stage Advanced Tumors Study
↗
August 01, 2022
Agenus (NASDAQ: AGEN) has dosed the first patient in the Phase 1 clinical study of AGEN1571 in advanced solid tumors. AGEN1571is a novel anti-ILT2 antibody designed to modulate tumor-associated...
Via
Benzinga
U.S. Stocks Turn Negative; 2U Shares Spike Higher
↗
June 29, 2022
U.S. stocks pared gains midway through trading, with all the three major indices turning lower on Wednesday.
Via
Benzinga
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
↗
July 06, 2022
Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.
Via
Benzinga
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
↗
June 30, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.